- Home
- KMI vs BSX Comparison
KMI vs BSX Comparison
Compare KMI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMI | BSX |
|---|---|---|
| Founded | 1936 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.8B | 68.0B |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KMI | BSX |
|---|---|---|
| Price | $30.93 | $43.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 22 |
| Target Price | $33.69 | ★ $93.18 |
| AVG Volume (30 Days) | 10.4M | ★ 17.7M |
| Earning Date | 04-22-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | 17.09 | ★ 55.20 |
| EPS | 0.82 | ★ 1.51 |
| Revenue | ★ $16,937,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $5.43 | $11.85 |
| Revenue Next Year | $4.52 | $10.16 |
| P/E Ratio | $38.30 | ★ $29.77 |
| Revenue Growth | 12.17 | ★ 12.49 |
| 52 Week Low | $25.60 | $42.20 |
| 52 Week High | $34.81 | $105.65 |
Technical Indicators
Market Signals| Indicator | KMI | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 43.06 | 33.10 |
| Support Level | $30.87 | $42.32 |
| Resistance Level | $32.94 | $46.37 |
| Average True Range (ATR) | 0.77 | 1.74 |
| MACD | -0.04 | -0.71 |
| Stochastic Oscillator | 22.60 | 0.50 |
Price Performance
Historical ComparisonAbout KMI Kinder Morgan Inc.
Kinder Morgan operates natural gas, crude oil, and refined products pipelines connecting producing regions to demand centers. It is principally involved in the gathering, storage, and transmission of natural gas across the continental United States. It also operates distribution centers for refined products along with the largest fleet of Jones Act-compliant tankers.
About BSX Boston Scientific Corporation
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.